CAR T-Cells in Multiple Myeloma: State of the Art and Future Directions

Despite recent therapeutic advances, the prognosis of multiple myeloma (MM) patients remains poor. Thus, new strategies to improve outcomes are imperative. Chimeric antigen receptor (CAR) T-cell therapy has changed the treatment landscape of B-cell malignancies, providing a potentially curative opti...

Full description

Saved in:
Bibliographic Details
Published in:Front Oncol
Main Authors: Rodríguez-Lobato, Luis Gerardo, Ganzetti, Maya, Fernández de Larrea, Carlos, Hudecek, Michael, Einsele, Hermann, Danhof, Sophia
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2020
Subjects:
Oncology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7399644/
https://ncbi.nlm.nih.gov/pubmed/32850376
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01243
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items